The FDA maintains a list of drug products that may not be
compounded at all because they have been found unsafe or not effective. The
agency proposes that additions to the list need not go through an advisory
committee. However, going through an advisory committee makes these additions
open to public comment, and that’s something we feel is vitally important. The FDA
is tremendously suspicious of innovation, so the agency should not sole
authority to determine what can go on the “do not compound” list.
Tell the FDA that their agency should not have sole
authority to add ingredients to a “do not compound” list, and that all
additions to the list should go through an advisory committee that is open to
Please personalize your comments
if you have the time!
Docket ID: FDA-1999-N-0194
Dear [Decision Maker],
Sincerely,[Your Name] [Your Address] [City, State ZIP]